HK Stock Market Move | Lens Technology (06613) surges by over 7%, Qiangnao Technology confirms completion of approximately 2 billion yuan financing, with the company exclusively undertaking its core hardware module mass production.
LanSi Technology (06613) rose more than 5% again, up 6.28% to HK$28.08 as of the time of publication, with a trading volume of HK$1.58 billion.
Lens Technology (06613) rose by over 5%, reaching an increase of 6.28% as of the time of publication, at 28.08 Hong Kong dollars, with a turnover of 1.58 billion Hong Kong dollars.
On the news front, it was recently reported by the media that Qiangnao Technology, one of the "Six Little Dragons" in Hangzhou, has completed a financing of about 2 billion yuan, setting the second largest financing record in the world in the brain-machine interface field after Neuralink. On January 8th, Qiangnao Technology stated, "It has indeed completed the financing, please refer to the information officially released by the company for specific details. The funds raised will be used to accelerate the core technology research and development of brain-machine interface, breakthroughs in extreme engineering, product scaling, and mass production."
Lens Technology previously stated on the investor interaction platform that Lens Technology is a strategic investor of Qiangnao Technology and has exclusively undertaken the mass production of Qiangnao Technology's core hardware modules. In November 2025, Lens Technology and Qiangnao Technology jointly donated a large number of intelligent bionic limbs to the Hunan Provincial Disabled Persons' Federation, with the core modules all coming from the Lens Technology production line.
At the same time, the company has had more than 10 years of deep cooperation with a major customer in North America and is its primary core supplier. Leveraging the mass production experience accumulated from projects like Qiangnao Technology and strong precision manufacturing capabilities, the company is actively seeking cooperation.
Related Articles

US Stock Market Move | Aktis Oncology (AKTS.US) listed on the US stock market, opening price increased by over 49%.

US Stock Market Move | Atlas Critical Minerals (ATCX.US) transferred to the Nasdaq, opening stock price dropped more than 35%.

US Stock Market Move | Rare earth concept continues to rise, Critical Metals (CRML.US) surges over 17%
US Stock Market Move | Aktis Oncology (AKTS.US) listed on the US stock market, opening price increased by over 49%.

US Stock Market Move | Atlas Critical Minerals (ATCX.US) transferred to the Nasdaq, opening stock price dropped more than 35%.

US Stock Market Move | Rare earth concept continues to rise, Critical Metals (CRML.US) surges over 17%

RECOMMEND

Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026

Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026

Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026


